Local anesthetics systemic toxicity in children: analysis of the French pharmacovigilance database
- PMID: 37355586
- PMCID: PMC10290397
- DOI: 10.1186/s12887-023-04126-7
Local anesthetics systemic toxicity in children: analysis of the French pharmacovigilance database
Abstract
Purpose: To characterize clinical profile of pediatric local anesthetic (LA) systemic toxicity (LAST) and to identify determinants of life-threatening outcomes.
Methods: Spontaneous reports notified to the French Pharmacovigilance Network were retrieved and followed by a case-by-case review, according to the following criteria: LA as suspected drug, age < 18 years, adverse drug reactions related to nervous system, cardiac, respiratory, psychiatric or general disorders. Multivariate logistic regression analysis was performed to identify factors leading to life-threatening reaction (i.e. continuous seizures or cardiorespiratory arrest).
Results: Among 512 cases retrieved, 64 LAST cases were included (neonates 11%, infants 30%, children 36%, adolescents 23%) mainly involving lidocaine (47%), lidocaine + prilocaine (22%) and ropivacaine (14%). Toxicity profiles were neurological (58%), cardiac (11%) or mixed (20%) and 7 patients (11%) developed methemoglobinemia. LAST was life-threatening for 23 patients (36%) and 2 patients died. Doses were above recommendations in 26 patients (41%) and were not different between life-threatening and non-life-threatening cases. The context of use (general and orthopedic surgery, p = 0.006) and the type of LA agent (lidocaine, p = 0.016) were independently associated with a life-threatening outcome.
Conclusion: In this national retrospective analysis, LAST in children appear to be a rare event. Neurological and cardiac signs were the most frequently reported reactions. LAST in children can be life-threatening, even at therapeutic doses. Although a fatal outcome may anecdotally occur, the vast majority of patients recovered after appropriate medical care.
Keywords: Adverse drug reaction; Local anesthetics; Pediatric; Pharmacovigilance; Systemic toxicity.
© 2023. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Figures
References
-
- Ruetsch YA, Böni T, Borgeat A. From cocaine to ropivacaine: the history of local anesthetic drugs. Curr Top Med Chem. 2001;1:175–82. - PubMed
-
- Christie LE, Picard J, Weinberg GL. Local anaesthetic systemic toxicity. Contin Educ Anaesth Crit Care Pain. 2015;15:136–142.
-
- Arthur GR, Covino BG. Pharmacokinetics of local anaesthetics. Baillières Clin Anaesthesiol. 1991;5:635–658. doi: 10.1016/S0950-3501(05)80047-9. - DOI
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
